Lori Sames, executive director of Hannah’s Hope Fund talks about her daughter’s rare neurologicial condition – giant axonal neuropathy – and the recent news that gene therapy may be a treatment option. Ms. Lames also comments on the need for the NIH to develop an institutional review board (IRB) specifically for gene therapy.
